About TARGAN
TARGAN is a company based in Morrisville (United States) founded in 2015 by Ramin Karimpour.. TARGAN has raised $65.9 million across 6 funding rounds from investors including Merck Animal Health, Mountain Group Partners and NovaQuest Capital Management. The company has 29 employees as of December 31, 2021. TARGAN operates in a competitive market with competitors including Merck Animal Health, Intervacc, VitamFero, Pacific GeneTech and Harrisvaccines, among others.
- Headquarter Morrisville, United States
- Employees 29 as on 31 Dec, 2021
- Founders Ramin Karimpour
-
Sectors
Agriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Targan Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$65.9 M (USD)
in 6 rounds
-
Latest Funding Round
$35 M (USD), Series C
May 25, 2022
-
Investors
Merck Animal Health
& 4 more
-
Employee Count
29
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of TARGAN
TARGAN has successfully raised a total of $65.9M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $35 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $35.0M
-
First Round
First Round
(01 Feb 2018)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2022 | Amount | Series C - TARGAN | Valuation | Mountain Group Partners , NovaQuest Capital Management | |
| May, 2021 | Amount | Series B - TARGAN | Valuation | Mountain Group Partners , Merck Animal Health | |
| May, 2021 | Amount | Series B - TARGAN | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TARGAN
TARGAN has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck Animal Health, Mountain Group Partners and NovaQuest Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is directed toward life sciences and technology sectors.
|
Founded Year | Domain | Location | |
|
PE firm focused on life science and healthcare companies
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments are provided by Oval Park Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TARGAN
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TARGAN
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Targan Comparisons
Competitors of TARGAN
TARGAN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck Animal Health, Intervacc, VitamFero, Pacific GeneTech and Harrisvaccines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccine technology is developed and supplied for livestock animals.
|
|
| domain | founded_year | HQ Location |
Recombinant vaccines for cattle, equine, and other livestock are developed.
|
|
| domain | founded_year | HQ Location |
Offers patented immunostimulating vaccines for livestock.
|
|
| domain | founded_year | HQ Location |
Developer of vaccines and gene delivery platform
|
|
| domain | founded_year | HQ Location |
Developer of vaccine technology for the treatment of infectious diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Targan
Frequently Asked Questions about TARGAN
When was TARGAN founded?
TARGAN was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is TARGAN located?
TARGAN is headquartered in Morrisville, United States.
Who is the current CEO of TARGAN?
Ramin Karimpour is the current CEO of TARGAN. They have also founded this company.
Is TARGAN a funded company?
TARGAN is a funded company, having raised a total of $65.9M across 6 funding rounds to date. The company's 1st funding round was a Series B of $7M, raised on Feb 01, 2018.
How many employees does TARGAN have?
As of Dec 31, 2021, the latest employee count at TARGAN is 29.
What does TARGAN do?
Founded in 2015 and based in Morrisville, United States, automated targeted vaccine delivery systems are developed by the company for livestock and aquaculture sectors. Technologies including high-speed imaging, microfluidics, artificial intelligence, and humane animal handling are integrated to provide vaccination solutions that reduce infection-related losses. Solutions are offered for aquaculture, pigs, and poultry operations.
Who are the top competitors of TARGAN?
TARGAN's top competitors include Merck Animal Health, Intervacc and Pacific GeneTech.
Who are TARGAN's investors?
TARGAN has 5 investors. Key investors include Merck Animal Health, Mountain Group Partners, NovaQuest Capital Management, Oval Park Capital, and National Science Foundation.